The primary aim of this review was to assess the effect of pharmacological agents administered to attenuate the haemodynamic response to tracheal intubation in paediatric patients up to 16 years of age undergoing elective surgery. Secondary aims were to identify adverse effects related to these agents, and the agents' roles in decreasing arrhythmias. A systematic search was conducted for articles listed in PubMed, CINAHL or the Cochrane database between January 1980 and June 2014. We included randomised controlled trials where the stated aim of the study included observing the effects of pharmacological agents on the haemodynamic response to tracheal intubation. The outcome measures were changes in mean, systolic and diastolic blood pressure and heart rate, adverse effects of drugs and arrhythmias. Sixteen publications with a total of 1408 children (ages two to 15 years) were identified. These studies varied in methodology and quality. Opioids were the commonest agents used and appeared to obtund the response in a dose-related manner. Fentanyl 2 µg/kg, remifentanil 1 µg/kg, sufentanil 0.1 and 0.2 µg/kg and alfentanil 25 µg/kg blunted the haemodynamic response. Remifentanil 3 µg/kg and sufentanil 0.3 µg/kg were the most effective in obliterating the response but led to hypotension in unstimulated patients. Opioid-related side-effects and arrhythmias were observed in few patients. We recommend that when required, the safe and effective doses identified in this review be used to obtund the haemodynamic response to intubation in paediatric patients, with close observation for the uncommon but recognised side-effects.
Introduction
Laryngoscopy and tracheal intubation cause sympathetically mediated increases in both blood pressure and heart rate. These changes have been extensively investigated in adults and can cause serious morbidity in high risk patients 1 
.
There is much less literature pertaining to these changes in children and their clinical importance is debatable 2 . The pattern of these circulatory changes is also different compared to adults due to differences in airway anatomy, autonomic cardiovascular regulation and pharmacokinetic and pharmacodynamic differences 3, 4 . Hence not all methods and drugs used in adults are applicable to children. Only short-acting opioids, alpha-agonists and local anaesthetics have been investigated.
The primary objective of this review was to determine the effectiveness of pharmacological agents administered preinduction to attenuate the blood pressure and heart rate response associated with tracheal intubation in children up to 16 years of age undergoing elective non-cardiac surgery. Our secondary objectives were to identify any adverse effects related to the agents and any arrhythmias encountered.
Materials and methods

Literature search methods
A systematic search was performed of the PubMed, Cochrane Controlled Trials Register and CINAHL databases for articles published between 1980 and June 2014 inclusive using the search items (including alternative spelling) for anaesthesia, paediatrics, tracheal intubation, cardiovascular response, blood pressure, heart rate, pharmacological agents (including opioids, beta adrenergic blocking agents and alpha adrenergic blocking agents), haemodynamics, arrhythmias and electrocardiographic (ECG) changes. Additional studies were identified through the reference list of relevant articles. The search was not restricted by language. Authors of identified publications were not contacted for additional information.
Study selection criteria
Inclusion criteria: Criteria for considering studies for this systematic review were as follows:
Type of studies: Only prospective randomised controlled trials (RCT) where the title or the objective of the study mentioned measuring the effect of pharmacological agents on the haemodynamic response to tracheal intubation were included. Both blinded and unblinded studies were included.
Type of participants: Studies including paediatric patients up to the age of 16 years, of any race and of either gender, undergoing elective surgery in the operating room were reviewed.
Type of interventions: Studies in which specific pharmacological agents were used through any route, for the purpose of suppressing the haemodynamic response associated with tracheal intubation were included.
Outcome measures: Studies that investigated one or more of the following outcome measures related to haemodynamic response were included.
Primary outcome measures: Changes in mean arterial pressure (MAP), systolic blood pressure (SBP) or diastolic blood pressure (DBP) following laryngoscopy and tracheal intubation (primary outcome).
Heart rate (HR) changes i.e. bradycardia (sinus rate <90 /minute in neonates and <60 /minute in older children), tachycardia (heart rate >200 /minute in neonates, >150 /minute in infants or 120 /minute in older children) 5 . Secondary outcome measures: Any adverse effects of the given drugs. Arrhythmias associated with a haemodynamic response. Exclusion Criteria: The following studies were excluded: Studies that investigated the effect of routine anaesthetic medications i.e. induction agents, inhalational agents or muscle relaxants on the haemodynamic response to tracheal intubation. We also excluded studies where target-controlled infusion was used for induction agents, e.g. propofol. These later studies were excluded because variation of dose of induction agent can affect the haemodynamic changes related to intubation 6 .
Data extraction, handling and analysis
All abstracts were independently screened by two of the authors.
The data were extracted individually by the two authors who documented information on participants, methods, interventions, outcomes and bias assessment. The reasons for inclusion or exclusion of studies were also recorded. Any disagreement was referred to the third author.
Risk of bias assessment was done by two authors according to standard descriptions for each type of bias. Random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants (performance bias), blinding of outcome assessment (detection bias), bias of incomplete outcome data (attrition bias) and selective reporting bias (reporting bias) were assessed. The definitions given in the Cochrane Handbook for Systematic Reviews of Intervention were followed 7 . The primary outcome was BP and HR changes. Due to variability in methodology and reporting, study comparison in treatment was reported as increased, decreased or no difference from control group.
Results
The flow chart of the literature search and study selection is shown in Figure 1 . We identified 31 articles but only 16 publications met our criteria [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Details of drugs used, dosage, route, observations and cardiac rhythm disturbances related to the response are shown in Table 1 . The details of premedication, induction agent, muscle relaxant used and method of observation of outcome are given in Table 2 .
A total of 1408 children between ages two to 15 years were included in these 16 publications. One hundred children received fentanyl, 220 received sufentanil, 464 received remifentanil, 91 received alfentanil, 40 received clonidine, 40 dexmedetomidine, 144 patients lignocaine, 20 received diazepam and 177 received saline. Drugs were given by the intravenous (IV) route in 14 studies, by the intranasal route in one study and by the oral route in one study.
The surgical procedures were elective plastic surgery in three studies, otological surgery in five studies, otological and ophthalmic surgery in one study and the surgical procedure was not mentioned in seven studies.
The haemodynamic response was reported as BP and HR changes in all trials, but the method of reporting was not consistent. Six studies 9, 13, 15, 17, 19, 22 documented the mean changes in MAP and HR. One study 16 documented the changes as more than 30% change from baseline and one study 15 measured the percentage change in BP and HR. Eight studies 8, [10] [11] [12] 14, 18, 21, 23 presented results as graphs alone. Additionally one study also presented the result as maximum percent change 10 . A saline control group was used in seven studies 9, 12, 14, 15, [16] [17] [18] while eight studies 10, 11, 13, [19] [20] [21] [22] [23] compared two groups using a standard alternative as control. One study did not use a placebo 8 . Arrhythmias were reported in six studies 9, 13, [15] [16] [17] 20 and additionally, ST segment changes were mentioned in one 15 . Opioid-related side-effects such as muscle rigidity, hypotension, and hypoxaemia were mentioned in fourteen studies ( Table 3 ).
All included studies were evaluated for their quality as mentioned in 'Materials and methods'. These results are shown in Table 4 .
Studies with opioids
Xue 15 et al compared IV administration of fentanyl 2 µg/kg over 30 seconds pre-induction with a placebo. Tracheal intubation caused a significant increase in HR and BP in both groups compared to baseline but the increase was less in the fentanyl group. Premature atrial contraction (PAC) and/ or junctional rhythm was seen in four patients in the saline group and two patients each in the fentanyl and sufentanil group.
Yang 19 et al compared pre-induction IV administration of fentanyl 2 µg/kg over 30 seconds with remifentanil 2 µg/kg. Fentanyl 2 µg/kg attenuated but did not abolish the SBP, DBP, MAP and HR changes. Remifentanil 2 µg/kg completely abolished the response but undesirable cardiovascular depression of more than 30% decrease versus baseline was observed.
Mireskandari 22 et al compared IV fentanyl 1 µg/kg (n=20) with remifentanil 1 µg/kg (n=20) and found that haemodynamic stability was better preserved with fentanyl compared to remifentanil.
Xue et al 15 compared fentanyl 2 µg/kg IV bolus (n=30) with sufentanil 0.2 µg/kg (n=30), two minutes before induction with propofol and found sufentanil to be more effective. The percentage change in BP after intubation was significantly different between opioid groups (20% with fentanyl versus 5% with sufentanil). The HR change was also significantly less in the sufentanil group (25% versus 10%). A percentage decrease of more than 30% in BP or HR was not seen in either group following intubation. The authors concluded that sufentanil provided more effective control of the intubation response compared to fentanyl. PAC, junctional rhythm and temporary ST depression was observed in two patients in each group. These changes reverted spontaneously.
Mireskandari et al 22 compared IV fentanyl 1 µg/kg (n=20) with sufentanil 0.1 µg/kg (n=20) followed by propofol 2.5 mg/kg and cisatracurium and found fentanyl provided better haemodynamic stablity.
Two studies, Xue et al 15 and Xue et al 16 , compared the effect of sufentanil in doses of 0.1 µg/kg (n=40), 0.2 µg/kg (n=70) and 0.3 µg/kg (n=40) with saline (n=70). A significant increase in BP and HR was seen after tracheal intubation following saline, sufentanil 0.1 µg/kg and 0.2 µg/kg but not with sufentanil 0.3 µg/kg. The authors concluded that sufentanil 0.2 µg/kg led to a dose-related attenuation of response and 0.3 µg/kg completely abolished it. PAC and/or junctional rhythm was seen in six patients in the placebo group, in four patients receiving 0.1 µg/kg sufentanil, in two patients given 0.2 µg/kg sufentanil, and in one patient given 0.3 µg/kg sufentanil. These changes resolved spontaneously within two minutes.
Xue et al 17 compared three doses of IV remifentanil (0.75 µg/kg, 1 µg/kg, and 1.25 µg/kg) with saline placebo in 120 patients. HR increased significantly after tracheal intubation with saline and remifentanil 0.75 µg/kg, remained stable with remifentanil 1 µg/kg, and significantly decreased with remifentanil 1.25 µg/kg compared to baseline. BP and HR values were significantly lower in all remifentanil groups compared to saline. The maximum values were lower with remifentanil 1 µg/kg and 1.25 µg/kg compared to 0.75 µg/kg.
PAC and/or junctional rhythm was observed in four patients given saline, three given remifentanil 0.75 µg/kg, two given remifentanil 1 µg/kg and one given remifentanil 1.25 µg/kg.
Blair et al 14 compared three doses of remifentanil (1, 2, and 3 µg/kg) with saline placebo in 112 children aged 3-12 years. BP decreased with remifentanil 2 µg/kg and 3 µg/kg but not in the saline and remifentanil 1 µg/kg group. HR increased after intubation with remifentanil 1 µg/kg and in the control group. BP decreased in the remifentanil 2 µg/kg and 3 µg/kg groups.
Park et al 18 compared two doses of remifentanil 1 µg/kg and 2 µg/kg with saline placebo in 96 children aged 1-7 years. MAP was higher in the saline group compared to remifentanil 1 µg/kg and 2 µg/kg. HR increased significantly in the saline group in response to laryngoscopy but a fall was observed with the two remifentanil groups.
Liao et al 20 compared remifentanil 2 µg/kg (n=50) to sufentanil 0.2 µg/kg (n=50). Compared with baseline values, BP and HR immediately following intubation significantly increased with sufentanil (12% increase) but decreased with remifentanil (23% decrease). A percentage change of more than 30% in SBP and HR from baseline was not statistically different between groups but a percentage decrease of more than 30% in both parameters was significantly more in the remifentanil group. Remifentanil completely abolished the haemodynamic response but at the expense of hypotension. PAC and/or junctional rhythm was observed in five patients in the remifentanil group and three patients in the sufentanil group. In another study 22 , there was no statistical difference in the response between sufentanil 0.1 µg/kg and remifentanil 1 µg/kg. Batra et al 13 compared two doses of remifentanil, 2 µg/kg and 3 µg/kg, in 40 children aged 5-10 years. No muscle relaxant was used. There was a significant decrease in HR and MAP compared to baseline with remifentanil 3 µg/kg at all timepoints compared to remifentanil 2 µg/kg. No patient had bradycardia or muscle rigidity.
Blair et al 14 compared three doses of remifentanil (1, 2, and 3 µg/kg). Remifentanil 1 µg/kg did not obtund the HR and BP. The BP decreased in both the 2 µg/kg and 3 µg/kg groups. The HR response and BP response were obtunded compared to remifentanil 1 µg/kg in both the 2 µg/kg and 3 µg/kg groups. The BP fell more in 3 µg/kg group. The authors also used atropine with propofol induction.
Park et al 18 compared two doses of remifentanil (1 µg/kg and 2 µg/kg) with 32 children in each group. No statistical difference was observed in the MAP and HR values in both remifentanil groups. Post-intubation hypotension (MAP less than 70 mmHg) was seen in two patients (6.3%) with the 1 µg/kg dose, and in five patients (15.6%) with the 2 µg/ kg dose. Yoon et al 21 compared three doses of remifentanil (1, 1.5 and 2 µg/kg) in 90 children aged 4-15 years. Remifentanil was administered following glycopyrrolate 5 µg/ kg, and thiopentone 4 mg/kg, followed by rocuronium. They recommended 2 µg/kg as the optimum dose, but suggested that BP dropped to a greater degree after three minutes.
Lindgren et al 9 compared three doses of IV alfentanil; 10, 25 and 50 µg/kg with a saline placebo given one minute before thiopentone and suxamethonium induction with 17 patients in each group. The BP response was not seen with 25 µg/kg or 50 µg/kg alfentanil. There was no effect on the HR response with 10 µg/kg alfentanil compared to baseline but it decreased with the 25 µg/kg and 50 µg/kg doses. The authors concluded that 25 µg/kg was ideal. Two patients in the control group had ventricular ectopics.
Robinson et al 11 compared alfentanil 15 µg/kg with remifentanil 1 µg/kg followed by propofol 4 mg/kg. No muscle relaxant was used. Both drugs attenuated the haemodynamic response to tracheal intubation with no statistical difference. Desaturation (SaO 2 less than 95%) was observed in three patients in the alfentanil group and four No mention 8% sevoflurane and O 2 6 l/min Paralytic medicine NIBP ECG monitored NIBP = non-invasive blood pressure; IM = intramuscular; PO = oral; BP = blood pressure; HR = heart rate; ECG = electrocardiograph; sec = second; min = minute.
patients in the remifentanil group as the opioid was given pre-induction with patients breathing spontaneously. Mireskandari et al 22 compared fentanyl 1 µg/kg (n=20) to alfentanil 10 µg/kg (n=20) and found that haemodynamic stability was better preserved with fentanyl.
Studies with local anaesthetics
Aoud et al 12 studied the effect of IV lignocaine 2 mg/kg in 46 children aged one to eight years compared to placebo (n=46) following inhalational induction with sevoflurane (endtidal concentration 5%) without using a muscle relaxant. They found that lignocaine attenuated the BP response. Splinter et al 8 used a single dose of IV lignocaine 1.5 mg/kg but varied the time of administration to one, two, three or four minutes before laryngoscopy. They concluded that 
Studies with alpha-2 adrenoreceptor selective agonists
Mikawa et al 10 compared two doses of oral clonidine 2 µg/kg and 4 µg/kg (n=20 in each group) to diazepam 0.4 mg/kg (n=20) in children aged 7-13 years and found that clonidine 4 µg/kg blunted the changes in BP and HR. This was not seen with the lower dose.
Wang et al 23 compared two doses of intranasal dexmedetomidine, 1 µg/kg and 2 µg/kg, administered 30 minutes before induction in 40 children aged 3-6 years and found better attenuation of MAP and HR responses with the 2 µg/kg dose.
Adverse effects
Adverse effects of drugs were mentioned in fourteen studies (Table 3) . Only one study reported bradycardia associated with remifentanil 2 µg/kg in two patients out of 50 19 . Some studies administered an anticholinergic drug before the short-acting opioid 10, 14, 18 and some had controlled the speed of injection. Chest wall rigidity was only seen in one study using alfentanil in a small percentage of patients 9 . Involuntary movements were observed in one patient given alfentanil 25 µg/kg, and in four patients given 50 µg/kg. Coughing was observed in a significant number of spontaneously breathing patients (range 53%-60%) with different doses of remifentanil (1, 1.5 and 2 µg/kg) 21 .
Desaturation was observed in three spontaneously breathing patients with alfentanil (15 µg/kg) and four patients with remifentanil 11 . No desaturation was reported in patients receiving assisted ventilation.
Discussion
The cardiovascular changes in response to noxious stimuli in the paediatric population may differ from those in adults for several reasons. Children have a greater parasympathetic cardiac drive and vagal preponderance 24 .
In adults the elasticity of major blood vessels decreases and atherosclerotic changes become more pronounced with ageing. In addition, coronary artery and cerebrovascular disease are virtually absent in the paediatric population. These differences do not allow the results of adult studies to be extrapolated to the paediatric population.
It is not clear whether the physiological changes related to tracheal intubation are associated with any morbidity in routine elective surgery in paediatric patients. Nevertheless, some evidence, mostly from case reports, documents potential harmful effects in patients with congenital heart disease, pulmonary hypertension, hypertension secondary to cerebrovascular disease and in patients with raised intracranial pressure 25 . For this reason, knowledge of the most effective agents to obtund the haemodynamic responses in children may be useful, as well as knowledge of potential side-effects of agents used for this purpose. This systematic review was conducted to assess the effect of different drugs administered pre-induction specifically to suppress these haemodynamic changes in children. We found that there were no studies in neonates and infants. Moreover, the sixteen studies identified in older children (aged 2-15 years) were heterogeneous with varied premedication, induction agents and techniques, use of muscle relaxants, inhalational agent concentration and timing of drugs used for obtunding this response. Even the same drug was given in different doses at different times in relation to tracheal intubation. Different authors reported the observed BP changes differently. Thus we were not able to combine data and subject it to meta-analysis.
Use of opioids showed an obtundation of both BP and HR when compared to placebo. In different studies remifentanil in doses of 0.75 µg/kg to 3 µg/kg attenuated the response in a dose-related manner. Sufentanil 0.1-0.3 µg/kg also resulted in dose-related attenuation. Fentanyl showed a variable response in different studies. Some of these differences can be explained on the basis of differential effects of different opioids on baroreceptors and central vagal tone 26 . Another reason could be that equipotent doses of opioids have not been studied in children and assumptions have been made in these trials based on adult data 27 . The two studies with lignocaine showed opposing results, the dose 2 mg/kg attenuated the BP increase in one study 12 but in another it did not alter the response when administered one, two, three or four minutes before intubation 8 . Both clonidine 4 µg/kg and dexmedetomidine 2 µg/kg attenuated the BP increase 10, 23 in children aged 3-13 years of age.
There were insufficient data using other agents to make any meaningful conclusions.
The side-effects reported were few. Not all studies mentioned the speed of injection of drugs, which may influence the incidence of these effects. The apparent rarity of these side-effects and the small sample size of the studies prevented us from making firm conclusions about the range or incidence of side-effects.
As far as the quality of trials was concerned, details of randomisation were available in only five of the studies, in the rest only the word 'randomisation' was mentioned, but no details were provided. Random sequence generation and allocation concealment was unclear in the majority of studies. In 37% of studies the blinding of participants, personnel and outcome assessors was unclear. Hence there were only a few high quality studies available for review. Trials of low quality tend to show larger intervention effects. All studies measured BP non-invasively as the authors did not feel justified to use an invasive technique. Electrocardiographic leads were standardised in only four studies and the majority did not mention the method of HR measurement. Also children can be stressed at induction and the level of anxiety may vary. This can affect the baseline HR which was not measured in any of the studies, and was not standardised across studies. Three studies used anticholinergic agents, either glycopyrrolate or atropine 10, 13, 21 . In four of the studies 10, 11, 13, 23 the authors were of the opinion that the use of a control group would introduce observer bias.
The studies also varied in the use of induction agents and muscle relaxants. Thiopentone was the induction agent in three, thiamylal in one, propofol in nine and an inhalational technique in one. A variety of muscle relaxants was used including suxamethonium, vecuronium, mivacurium, rocuronium and cisatracurium. No muscle relaxant was used in four studies. This made the comparison between studies difficult as both induction agents and muscle relaxants have been shown to have a variable effect on haemodynamic response 6, 28 . The potency of the drugs used to obtund the response to intubation was extrapolated from adults. This data in children is lacking and serum level of drugs was not measured in any study. Previous studies have reported that the opioid doses for blunting haemodynamic responses related to laryngoscopy in paediatric patients are different from adults 16, 17, 21 . Fentanyl boluses in infants have resulted in lower plasma levels compared to adults 30 . Similarly, the volume of distribution of sufentanil in children between 2-8 years has been found to be 1.5 times greater than adults when expressed as a fraction of body weight 30 . Studies on the clinical pharmacodynamics of remifentanil in children have shown that children require a remifentanil infusion rate twice that of adults to block haemodynamic responses to skin incision under intravenous or sevoflurane anaesthesia 31, 32 . Hence there is a need to study the appropriate doses of drugs used for obtunding this response in children. Some investigators used remifentanil as a bolus, rather than continuous infusion which is a preferable technique considering its short half-life.
Interpretation of review findings and recommendations
This review shows that there is a lack of studies on the effect of pharmacological agents on the haemodynamic response to tracheal intubation in neonates and infants. Other studies vary in methodology, dosage and timing of anaesthetic and study drugs, anaesthesia induction techniques and presentation format of results, hence making direct comparisons difficult even in studies where the same drug was used. However some generalisations that can be inferred from this review are as follows:
Opioids are the commonest pharmacological group that has been studied in children for obtunding the haemodynamic response to intubation.
Remifentanil 0.75 µg/kg was ineffective (one study), 1 µg/kg attenuated the response (six studies), 1.25 µg/kg abolished the response and also maintained haemodynamic stability (one study) and 1.5 µg/kg attenuated the response more than 1 µg/kg (one study). Higher doses of 2 µg/kg and 3 µg/kg abolished the response completely but at the expense of hypotension in unstimulated patients (six studies).
Fentanyl 1 µg/kg and 2 µg/kg attenuated the BP response. The effect on HR was equivocal.
Sufentanil 0.1-0.2 µg/kg attenuated the response, 0.3 µg/kg completely abolished the response, but a decrease in HR and SBP of more than 30% was observed in 5%-10% patients.
Alfentanil 25 µg/kg was found to be the most effective dose in attenuating the response.
Lignocaine 2 mg/kg was partially effective in attenuating the BP but not HR response.
Dexmedetomidine 2 µg/kg attenuated both the BP and HR response.
Clonidine 4 µg/kg attenuated the response. These findings need to be interpreted keeping in mind the variable quality of the studies. Earlier studies conducted between 1990-2003 had a high risk of bias, whereas those conducted between 2004 and 2014 are generally moderate to good in quality assessment (Table 4) .
Limitations of this review include the paucity of data available, the variable quality of the studies and the wide age range of the children studied (2-15 years). There were no studies of intubation responses available comparing different age groups e.g. in infants, preschool children and adolescents, despite the fact that their responses may vary due to airway and other physiological changes that occur with age. Another limitation was that all studies were conducted in American Society of Anesthesiologists Physical Status 1 or 2 haemodynamically stable patients and the results may not be directly applicable to other patients. Patients with congenital heart disease, pulmonary hypertension, renovascular disease, and raised intracranial pressure may be more vulnerable to the changes associated with tracheal intubation but no studies are available in these children.
In conclusion, the following drugs attenuated the BP and HR response to tracheal intubation in paediatric patients: fentanyl 2 µg/kg, remifentanil 1 µg/kg, sufentanil 0.1 µg/kg and 0.2 µg/kg, and alfentanil 25 µg/kg. Remifentanil 3 µg/ kg and sufentanil 0.3 µg/kg appear to completely abolish the response but at the expense of cardiovascular instability in unstimulated patients before the start of surgery. In the nonopioid group, lignocaine 2 mg/kg attenuated the BP response only. Oral clonidine 4 µg/kg and oral dexmedetomidine 4 µg/kg attenuated the response in one study each. Sideeffects such as chest wall rigidity, oxygen desaturation and coughing were few and seen only in spontaneously breathing patients who received alfentanil or remifentanil. Arrhythmias were observed in seven studies, but in all cases these were transient. While adverse effects were rare, the studies had insufficient power to fully assess morbidity. Therefore, we recommend that when required, the safe and effective doses identified in this review be used to obtund the haemodynamic response to tracheal intubation in paediatric patients, but we recommend close observation for potential side-effects.
